Mezagitamab Antibody
Mezagitamab (TAK-079) is a human anti-CD38 monoclonal antibody that depletes target cells via ADCC and CDC. It is primarily investigated in preclinical and clinical research for relapsed/refractory multiple myeloma, with studies exploring its efficacy in both in vitro assays and in vivo models.
Product Specifications
Product Name Alternative
CD38, TAK079, TAK-079
Target
CD38, Apoptosis
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation
Concentration
6.63 mg/mL
Purity
97.50% (May vary between batches)
Molecular Weight
144.4 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
